Tomorrow at 9.00 am France time @slice_inr, co-PI's @CostalatV@CarolineArquiz1@lapergue6@TudorGJovin will present primary results of LASTE (randomized trial of MT in large core pts. ASPECTS 0-5). Median core = 150 ml with 56% ASPECTS 0-2.Please join us: https://t.co/jQL4a0fdUU
In this RCT, in nonurban areas in Catalonia, Spain, there was no significant difference in 90-day neurological outcomes btwn transportation to a local stroke center vs a thrombectomy-capable referral center in pts w suspected large-vessel occlusion stroke. https://t.co/2N5YEI2h9y
Latest in basic science - https://t.co/8J09owR73A - Li J et al showed up to 79% variability in devices’ tracking performance. Hybrid coil and braid reinforcement configuration and DACs’ distal wall thickness are significant contributory factors to ease navigation. @marcriboj
Clinical Results of the Advanced Neurovascular Access Catheter System Combined With a Stent Retriever in Acute Ischemic Stroke (SOLONDA) https://t.co/PQ7A8XVkIU
Direct to Angiography Suite Without Stopping for Computed Tomography Imaging in Acute Stroke https://t.co/Ee7wi3ahwL via @JAMANeuro part of @JAMANetwork Why not DTAS your next case?
Dr. Jovin is right, we determined the detrimental effect of additional passes, recanalization with any passes is still better than NO recanalization. When to Stop
Detrimental Effect of Device Passes. https://t.co/WP2MkWKMHN
This proposal reflects flawed logic. Ample evidence exists that # of passes correlate with outcomes BUT also that reperfusion is better than no reperfusion. Outcomes in > 3 pass pts should be compared to non treated patients and not with
≤ 3 pass pts. https://t.co/t9Qy53OdVE
Se han publicado oficialmente los resultado del #BASIC trial
Ya hemos hablado harto desde su análisis durante el #ESOWSO2020
No cambiará la práctica x el momento
Lo mejor? El nuevo formato de resumen del @NEJM
Ps: 👏 Brazilian team
https://t.co/VU595VGR0z
Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion | NEJM https://t.co/g0I8zeaGdT
Inability to show a significant difference in outcomes does not mean there is no difference. Had the study not been redesigned mid trial, results would likely have favored thrombectomy.
Direct to Angio Suite (DTAS) workflow on stroke patient:
Admission NIHSS= 16
3 hours since stroke onset
LVO suspected
Door to reperfusion (Aspiration): 18 minutes
NIHSS 24h= 1
Every 30 minutes delay before treatment reduces the chance of a good outcome by 14%
JNIS Latest Content
Fernandez-Sanchez, @marcriboj, @_AdnanSiddiqui, @o_arad et al use an in vitro #stroke#thrombectomy model to evaluate the suction force of a novel aspiration catheter https://t.co/hlOsod1B3C